Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41541-021-00313-8 http://scihub22266oqcxt.onion/10.1038/s41541-021-00313-8 33767200!7994717!33767200     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       NPJ+Vaccines 2021 ; 6 (1): 44 Nephropedia Template TP {{tp|p=33767200|t=2021. The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization |pdf=|usr=}}{{33767200}} gab.com Text The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization JO: NPJ Vaccines http://www.kidney.de/pget.php?&tw=1&pmid=33767200 #FOAvip Initial COVID-19 vaccine candidates were based on the original sequence of SARS-CoV-2. However, the virus has since accumulated mutations, among which the spike D614G is dominant in circulating virus, raising questions about potential virus escape from vaccine-elicited immunity. Here, we report that the D614G mutation modestly reduced (1.7-2.4-fold) SARS-CoV-2 neutralization by BNT162b2 vaccine-elicited mouse, rhesus, and human sera, concurring with the 95% vaccine efficacy observed in clinical trial. Twit Text FOAVip The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization ????NPJ Vaccines http://www.kidney.de/pget.php?&tw=1&pmid=33767200 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33767200 #FOAvip English Wikipedia <ref>{{Cite pmid|33767200}}</ref> The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization #MMPMID33767200 Zou J; Xie X; Fontes-Garfias CR; Swanson KA; Kanevsky I; Tompkins K; Cutler M; Cooper D; Dormitzer PR; Shi PY NPJ Vaccines 2021[Mar]; 6 (1): 44 PMID33767200show ga Initial COVID-19 vaccine candidates were based on the original sequence of SARS-CoV-2. However, the virus has since accumulated mutations, among which the spike D614G is dominant in circulating virus, raising questions about potential virus escape from vaccine-elicited immunity. Here, we report that the D614G mutation modestly reduced (1.7-2.4-fold) SARS-CoV-2 neutralization by BNT162b2 vaccine-elicited mouse, rhesus, and human sera, concurring with the 95% vaccine efficacy observed in clinical trial. äThe effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited (epmc).pdf DeepDyve Pubget Overpricing